Philip Ashton-Rickardt

Philip Ashton-Rickardt

Company: AZTherapies

Job title: Senior Vice President, Immunology

Seminars:

Live Speaker Q&A 11:05 am

Read more

day: Day One

Small Molecule & Cell Therapies for Neurodegenerative Diseases 10:15 am

• Anti-inflammatory small molecules can dampen the pathogenic activation of microglia • These anti-inflammatories are under evaluation in clinical trials on Alzheimer’s disease and Amyotrophic lateral sclerosis patients • Engineered T cell therapies have the potential to dampen neuroinflammation and promote neuro-regenerationRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.